RxDoctor Payments Data

Tania Ferguson, MD

Orthopaedic Trauma · Nashville, TNNPI 1831169556

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $137,541 of the $155,273 with a category attached, or 88.6%. Medical Device Business Services, Inc. accounts for 71.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $65,507 and has fallen 70.3% since, to $19,445 in 2025. Among orthopaedic trauma clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$155,273in general payments, 2019–2025

Across 101 payments — averaging $1537.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$111K
  • Medacta USA, Inc.$32K
  • Synthes USA Products LLC$7K
  • Synthes GmbH$5K
  • Johnson & Johnson$1K
  • Smith+Nephew$290
  • plus $150 from 3 others

What the payments were for

  • Consulting fees$137,54189%
  • Speaking & faculty fees$2,5002%
  • Travel & lodging$12,3198%
  • Food & beverage$2,9132%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$155,273 in reported general payments places this provider in the 95th percentile of 27 orthopaedic trauma providers in Tennessee.

See all orthopaedic trauma providers in Tennessee

Medicare billing

Part B allowed, 2024
$128,874
Medicare patients
133
Services billed
602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$6,191
Celecoxib162$3,669
Tranexamic Acid41$1,019
Meloxicam73$347
Cephalexin64$281
Oxycodone Hcl24$104
Cyclobenzaprine Hcl18$103
Tramadol Hcl30$84
Gabapentin20$52
Pregabalin14$44
Tamsulosin Hcl12$16

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$1,075$6,19111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 27 orthopaedic trauma providers in Tennessee.

Other orthopaedic trauma in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →